$368,302
＋2%
Director T2 Commercialization
2021
$304k related
51 hrs/wk
$65k other
--
Director T2 Commercialization at Hjf Medical Research International Inc.
Fiscal year ended September 30, 2021. Published on January 25, 2026.
Total compensation
Mark Scher has been listed as an employee of Hjf Medical Research International Inc. in Form 990 filings since fiscal year 2020. Total compensation for Mark Scher has increased by 2% from 2020 to 2021.